Brought to you by 
Astra in 5-year genomic research deal with Millennium
27 Mar 2000
Executive Summary
In its first genomic deal, a 5-year collaboration valued up to $53.3mm, Astra will help finance development of Millennium's genetic research in the area of inflammatory respiratory diseases, including asthma, hay fever and bronchitis.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Concluded
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Astra in 5-year genomic research deal with Millennium
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice